Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda M Griffith

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Blood|October 13, 2017
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history studyJennifer Heimall, Brent R Logan, Morton J Cowan, et al.
Journal of Human Immunity|January 29, 2026
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC studyVirdette L Brumm, Sharon A Kidd, Brent R Logan, et al.
Transplantation and Cellular Therapy|July 4, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms reportDaniel Wolff, Vedran Radojcic, Robert Lafyatis, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2024
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium studyEyal Grunebaum, Danielle E Arnold, Brent Logan, et al.
The New England Journal of Medicine|July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.
Transplantation and Cellular Therapy|October 4, 2025
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC ReportDanielle E Arnold, Jennifer W Leiding, Brent Logan, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2022
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 DefinitionsChristopher C Dvorak, Elie Haddad, Jennifer Heimall, et al.
Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Blood|October 13, 2017
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history studyJennifer Heimall, Brent R Logan, Morton J Cowan, et al.
Journal of Human Immunity|January 29, 2026
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC studyVirdette L Brumm, Sharon A Kidd, Brent R Logan, et al.
Transplantation and Cellular Therapy|July 4, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms reportDaniel Wolff, Vedran Radojcic, Robert Lafyatis, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2024
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A  Primary Immune Deficiency Treatment Consortium studyEyal Grunebaum, Danielle E Arnold, Brent Logan, et al.
The New England Journal of Medicine|July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
The New England Journal of Medicine|January 4, 2018
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith M Sullivan, Ellen A Goldmuntz, Lynette Keyes-Elstein, et al.
Transplantation and Cellular Therapy|October 4, 2025
Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC ReportDanielle E Arnold, Jennifer W Leiding, Brent Logan, et al.
The Journal of Allergy and Clinical Immunology|December 1, 2022
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 DefinitionsChristopher C Dvorak, Elie Haddad, Jennifer Heimall, et al.
Journal of Clinical Immunology|August 4, 2019
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCTRebecca A Marsh, Jennifer W Leiding, Brent R Logan, et al.
The Journal of Allergy and Clinical Immunology|October 22, 2013
Primary Immune Deficiency Treatment Consortium (PIDTC) reportLinda M Griffith, Morton J Cowan, Luigi D Notarangelo, et al.
Pageof 6